COVID-19-We urgently need to start developing an exit strategy.
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Coronavirus Infections
/ diagnosis
Delivery of Health Care
Humans
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Pandemics
/ prevention & control
Personal Protective Equipment
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Travel
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
13
04
2020
accepted:
14
04
2020
pubmed:
4
5
2020
medline:
29
7
2020
entrez:
4
5
2020
Statut:
ppublish
Résumé
The purpose of this perspective is to review the options countries have to exit the draconian "lockdowns" in a carefully staged manner. Experts from different countries experiencing Corona Virus Infectious Disease 2019 (COVID-19) reviewed evidence and country-specific approaches and the results of their interventions. Three factors are essential: 1. Reintroduction from countries with ongoing community transmission; 2. The need for extensive testing capacity and widespread community testing, and 3. An adequate supply of personal protective equipment, PPE, to protect health care workers. Discussed at length are lifting physical distancing, how to open manufacturing and construction, logistics, and the opening of higher educational institutions and schools. The use of electronic surveillance is considered. Each country should decide on the best path forward. However, we can learn from each other, and the approaches are, in reality, very similar.
Identifiants
pubmed: 32360552
pii: S1201-9712(20)30251-4
doi: 10.1016/j.ijid.2020.04.035
pmc: PMC7188647
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-239Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
Lancet. 2020 Mar 21;395(10228):945
pubmed: 32142626
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):419-421
pubmed: 32271724
Int J Infect Dis. 2020 May;94:88-90
pubmed: 32305518
J Travel Med. 2020 May 18;27(3):
pubmed: 32167146
Osong Public Health Res Perspect. 2015 Aug;6(4):269-78
pubmed: 26473095
Lancet Infect Dis. 2020 Jul;20(7):793-802
pubmed: 32247326
Korean J Intern Med. 2018 Mar;33(2):233-246
pubmed: 29506344
Int J Biol Sci. 2020 Mar 15;16(10):1698-1707
pubmed: 32226287
Lancet. 2020 Apr 4;395(10230):1101-1102
pubmed: 32247384
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371
Int J Epidemiol. 2020 Aug 1;49(4):1063-1066
pubmed: 32232402
Lancet. 2020 Apr 25;395(10233):1382-1393
pubmed: 32277878
Osong Public Health Res Perspect. 2020 Feb;11(1):60-63
pubmed: 32149043
Lancet. 2020 Mar 14;395(10227):848-850
pubmed: 32151326